Syneron Medical Ltd. (NASDAQ:ELOS)
| CAPS Rating |
|
|---|---|
| Open | $10.36 |
| Previous Close | $10.50 |
| Daily Range | $10.36 - $10.77 |
| 52-Week Range | $8.91 - $14.92 |
| Market Cap | $366.17M |
| P/E Ratio | 158.80 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 94,528 |
| Average Daily Volume | 0 |
How do you think ELOS will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ELOS Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ELOS News and Commentary
- Syneron Medical Goes Red – The Motley Fool
- Cutera Wraps Up IRIDEX Buy - Analyst Blog – NASDAQ
- Syneron Medical Intros Evolastin - Analyst Blog – NASDAQ
- 4-Star Stocks Poised to Pop: Syneron Medical – The Motley Fool
- Solta's LIPOSONIX Reaches the U.S. - Analyst Blog – NASDAQ
- The Zacks Analyst Blog Highlights: Cutera, IRIDEX, Cynosure, Palomar Medical Technologies and Synero – NASDAQ
- Cutera Buys IRIDEX's Aesthetic Biz - Analyst Blog – NASDAQ
- 3 Top Stocks at Half-Price – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
- Syneron Medical CEO Discusses F3Q2011 Results -- Earnings Call Transcript – SeekingAlpha Transcripts
- Are Shorts Watching Syneron Medical? – The Motley Fool
- Syneron Medical CEO Discusses Q1 2011 - Earnings Call Transcript – SeekingAlpha Transcripts
- Top 30 Most Oversold and Undervalued Stocks by Analyst Target Price – SeekingAlpha
- Cynosure Passes This Key Test – The Motley Fool
- JP Morgan's Extremely Bullish New Stock Picks – SeekingAlpha
- JPMorgan's Extremely Bullish New Stock Picks – SeekingAlpha
- The Earnings Season Top 50 – SeekingAlpha
- Syneron Medical CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha
- Syneron Medical CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Top 30 Most Undervalued Small Cap Stocks by Analyst Target Price – SeekingAlpha

RSS Headlines
Fool UK